Fidelity Investments’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Buy
30,704
+17,125
+126% +$117K ﹤0.01% 3419
2025
Q4
$26.9K Buy
13,579
+2,665
+24% +$6.04K ﹤0.01% 4352
2025
Q3
$26.8K Sell
10,914
-3,227
-23% -$8.31K ﹤0.01% 4246
2025
Q2
$37.3K Sell
14,141
-123,772
-90% -$333K ﹤0.01% 4029
2025
Q1
$415K Buy
137,913
+24,072
+21% +$73K ﹤0.01% 2962
2024
Q4
$291K Buy
113,841
+105,689
+1,296% +$440K ﹤0.01% 3118
2024
Q3
$30.3K Sell
8,152
-3,608
-31% -$16.7K ﹤0.01% 4004
2024
Q2
$74.3K Sell
11,760
-7,380
-39% -$48.7K ﹤0.01% 3431
2024
Q1
$103K Buy
19,140
+1,926
+11% +$8.72K ﹤0.01% 3277
2023
Q4
$86.4K Buy
17,214
+2,333
+16% +$7.32K ﹤0.01% 3273
2023
Q3
$25.1K Buy
14,881
+9,749
+190% +$19.6K ﹤0.01% 3691
2023
Q2
$14.3K Buy
5,132
+224
+5% +$633 ﹤0.01% 4010
2023
Q1
$8.93K Sell
4,908
-4,537
-48% -$14.1K ﹤0.01% 4169
2022
Q4
$47.9K Sell
9,445
-414
-4% -$2.27K ﹤0.01% 3450
2022
Q3
$49K Buy
9,859
+850
+9% +$3.87K ﹤0.01% 3498
2022
Q2
$33K Sell
9,009
-100,425
-92% -$403K ﹤0.01% 3715
2022
Q1
$614K Buy
+109,434
New +$671K ﹤0.01% 2924
2021
Q3
Sell
-100
Closed -$1K 4671
2021
Q2
$1K Buy
100
+98
+4,900% +$1.62K ﹤0.01% 4044
2021
Q1
$0 Buy
+2
New +$52 ﹤0.01% 4250
2018
Q2
Sell
-230,213
Closed -$896K 2673
2018
Q1
$896K Sell
230,213
-1,038,937
-82% -$4.56M ﹤0.01% 2454
2017
Q4
$5.7M Sell
1,269,150
-364,049
-22% -$1.72M ﹤0.01% 2131
2017
Q3
$8.95M Sell
1,633,199
-102,601
-6% -$632K ﹤0.01% 1981
2017
Q2
$13.2M Sell
1,735,800
-10,700
-0.6% -$46.2K ﹤0.01% 1839
2017
Q1
$6.2M Sell
1,746,500
-418,445
-19% -$2.07M ﹤0.01% 2123
2016
Q4
$12.4M Hold
2,164,945
﹤0.01% 1889
2016
Q3
$16.8M Sell
2,164,945
-115,632
-5% -$864K ﹤0.01% 1758
2016
Q2
$14.2M Sell
2,280,577
-48,818
-2% -$379K ﹤0.01% 1816
2016
Q1
$19.1M Sell
2,329,395
-163,400
-7% -$1.54M ﹤0.01% 1680
2015
Q4
$43.2M Buy
2,492,795
+964,495
+63% +$14.3M 0.01% 1312
2015
Q3
$17.5M Buy
+1,528,300
New +$33.4M ﹤0.01% 1702

Other funds holding IBRX